ライフサイエンスコーパス: respiratory syncytial virus

1 account for 80% of the phosphoprotein of the respiratory syncytial virus.

2 halomyocarditis virus, human rhinovirus, and respiratory syncytial virus.

3 evere forms of disease associated with human respiratory syncytial virus.

4 airway allergen challenge or infection with respiratory syncytial virus.

5 so includes rabies virus, measles virus, and respiratory syncytial virus.

6 rly life lower respiratory illness caused by respiratory syncytial virus (41.2% vs. 21.4%; P = 0.001)

7 virus (107 [12.8%]), adenovirus (64 [6.0%]), respiratory syncytial virus (60 [5.6%]), and Streptococc

8 Respiratory syncytial virus (83%) and human rhinovirus (

9 l therapeutic in patients at risk to develop respiratory syncytial virus acute lower respiratory trac

10 ty than oropharyngeal swabs for detection of respiratory syncytial virus, adenovirus, human metapneum

11 s to individual viruses including influenza, respiratory syncytial virus and dengue, but the generali

12 espiratory pathogens Pseudomonas aeruginosa, respiratory syncytial virus and influenza viruses, with

13 e design of a bivalent pediatric vaccine for respiratory syncytial virus and parainfluenza virus type

14 immunization appears to be within reach for respiratory syncytial virus and promising for influenza

15 1 effectively restricts replication of human respiratory syncytial virus and rhinoviruses.

16 thematical models of 2 childhood infections (respiratory syncytial virus and rotavirus) to illustrate

17 S, malaria, and tuberculosis, as well as for respiratory syncytial virus and those chronic and debili

18 Detections of influenza, respiratory syncytial virus, and human metapneumovirus a

19 Detections of influenza, respiratory syncytial virus, and human metapneumovirus w

20 nuate human pathogens, including poliovirus, respiratory syncytial virus, and influenza virus.

21 th these conditions, with influenza viruses, respiratory syncytial virus, and rhinoviruses being the

22 ns include measles virus, mumps virus, human respiratory syncytial virus, and the zoonotic paramyxovi

23 Respiratory syncytial virus antigens were detected in ci

24 Group B streptococcus and respiratory syncytial virus are leading causes of infant

25 Collectively, our results show that for respiratory syncytial virus assembly, viral filaments ar

26 encing, was used to investigate a nosocomial respiratory syncytial virus-B (RSV-B) outbreak in a hema

27 Respiratory syncytial virus-bronchiolitis is a major ind

28 Respiratory syncytial virus caused 66% of the bronchioli

29 irus acute lower respiratory tract infection.Respiratory syncytial virus causes lung infections in ch

30 viruses associated with acute otitis media, respiratory syncytial virus continues to be the most com

31 red with cellular antiviral activity against respiratory syncytial virus (CPE EC50 = 2.1 muM), modera

32 is B virus, enterovirus 71, influenza virus, respiratory syncytial virus, dengue virus, and Ebola vir

33 Severe respiratory syncytial virus disease can be prevented by

34 ated with reduced prevalence and severity of respiratory syncytial virus disease in the first few wee

35 ogen that serves as a model for severe human respiratory syncytial virus disease.

36 d the genome sequence of an unpassaged human respiratory syncytial virus from a sample obtained direc

37 eport the structure of JNJ-53718678 bound to respiratory syncytial virus fusion (F) protein in its pr

38 h the binding mode of JNJ-53718678 and other respiratory syncytial virus fusion inhibitors.

39 soybean agglutinin to selectively label the respiratory syncytial virus G protein in living cells wi

40 The human respiratory syncytial virus G protein plays an important

41 ch, we discovered that plasma membrane-bound respiratory syncytial virus G rapidly recycles from the

42 d the highest mortality risk, and those with respiratory syncytial virus had the lowest.

43 The development of vaccines for respiratory syncytial virus has been hampered by a lack

44 Human respiratory syncytial virus (hRSV) and human metapneumov

45 The human respiratory syncytial virus (HRSV) core viral RNA polyme

46 The human respiratory syncytial virus (hRSV) fusion (F) protein is

47 Human respiratory syncytial virus (hRSV) is a leading cause of

48 Human respiratory syncytial virus (hRSV) is a major cause of m

49 Human respiratory syncytial virus (HRSV) is a major cause of s

50 Human respiratory syncytial virus (HRSV) is a major pediatric

51 Human respiratory syncytial virus (hRSV) is responsible for se

52 Human respiratory syncytial virus (hRSV) is the leading cause

53 Human respiratory syncytial virus (hRSV) is the leading cause

54 Human respiratory syncytial virus (HRSV) is the most important

55 Human respiratory syncytial virus (HRSV) represents a major he

56 Human respiratory syncytial virus (hRSV) vaccine development h

57 A molecular epidemiological study of human respiratory syncytial virus (HRSV) was conducted to exam

58 es were compared with those induced by human respiratory syncytial virus (HRSV), a virus with a simil

59 ajor difference with pre-fusion F from human respiratory syncytial virus (hRSV), and collectively our

60 nt human and animal pathogens, such as human respiratory syncytial virus (hRSV), hMPV, bovine RSV, an

61 nt human and animal pathogens, such as human respiratory syncytial virus (hRSV), hMPV, bovine RSV, an

62 The paramyxoviruses human respiratory syncytial virus (hRSV), human metapneumoviru

63 Along with the human respiratory syncytial virus (hRSV), the human metapneumo

64 For human respiratory syncytial virus (hRSV), VLP assembly is poor

65 ent model to study the closely related human respiratory syncytial virus (hRSV).

66 onia virus of mice (PVM) is a model of human respiratory syncytial virus (hRSV).

67 Molecular analyses showed that human respiratory syncytial viruses (HRSV) and human metapneum

68 thogenic viruses, including influenza virus, respiratory syncytial virus, human immunodeficiency viru

69 s virus, mumps virus, parainfluenza viruses, respiratory syncytial virus, human metapneumovirus, and

70 protection against group B streptococcus and respiratory syncytial virus, identifies knowledge gaps r

71 treatment is delayed until external signs of respiratory syncytial virus illness have become visible.

72 athogen was identified in 91.9% of patients (respiratory syncytial virus in 51.4%, human rhinovirus i

73 espiratory viruses, such as rhinoviruses and respiratory syncytial virus, in asthma development.

74 Finally, influenza- and respiratory syncytial virus-induced CXCL-10 was also fou

75 In contrast, reduced respiratory syncytial virus-induced IL-8 responses and i

76 2.4; 95% confidence interval [CI], 1.4-3.9), respiratory syncytial virus infection (aRR, 1.9; 95% CI,

77 Respiratory syncytial virus infection induced strong and

78 Here we report that during Sendai and respiratory syncytial virus infections DVGs selectively

79 with immunomodulators) for the treatment of respiratory syncytial virus infections in HM patients an

80 ategies to prevent group B streptococcus and respiratory syncytial virus infections, among others.

81 experimentally challenged with either bovine respiratory syncytial virus, infectious bovine rhinotrac

82 G protein in living cells without disrupting respiratory syncytial virus infectivity or filament form

83 Respiratory syncytial virus infects CD4+ and CD8+ T cell

84 Respiratory syncytial virus is a major cause of acute lo

85 resence of maternal IgG antibody specific to respiratory syncytial virus is associated with reduced p

86 eloped an immunodeficiency scoring index for respiratory syncytial virus (ISI-RSV) infection, based o

87 aviridae (Lassa virus), and Paramyxoviridae (respiratory syncytial virus, Nipah virus) to suppress in

88 virus, hepatitis C virus, influenza A virus, respiratory syncytial virus, Nipah virus, Lassa virus, a

89 vide protein binding sites recognized by the respiratory syncytial virus nucleoprotein and compatible

90 (odds ratio = 3.3; 95% CI, 1.5-7.1), but not respiratory syncytial virus (odds ratio = 1.0; 95% CI, 0

91 to Feb 3, 2015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial

92 those of other respiratory pathogens: human respiratory syncytial virus, parainfluenza virus 5, and

93 d by multiplex polymerase chain reaction for respiratory syncytial virus, parainfluenza viruses 1-4,

94 iruses, rhinoviruses, human metapneumovirus, respiratory syncytial virus, parainfluenza viruses, and

95 A respiratory viruses (NIRVs), which include respiratory syncytial virus, parainfluenza viruses, coro

96 ynamic formation of filamentous and branched respiratory syncytial virus particles, and assembly with

97 unisation initiatives-group B streptococcus, respiratory syncytial virus, pertussis, and influenza.

98 with small-molecule antivirals specific for respiratory syncytial virus presents an important therap

99 y replication-competent IAV-WSN strain and a respiratory syncytial virus reporter strain for the simu

100 ydia, Haemophilus influenzae, influenza, and respiratory syncytial virus respiratory tract infections

101 s for nonatopic asthma were the first severe respiratory syncytial virus/rhinovirus-negative wheezing

102 Nine respiratory virus types (respiratory syncytial virus, rhinoviruses, other picorna

103 in primer-extension assays using a surrogate respiratory syncytial virus RNA polymerase.

104 ated with TLR4, TLR7/8-selective ligands, or respiratory syncytial virus (RSV) +/- 1,25(OH)2D3.

105 Human respiratory syncytial virus (RSV) A ON1 genotype, first

106 o determine the association of influenza and respiratory syncytial virus (RSV) activity with risk of

107 Respiratory syncytial virus (RSV) and human metapneumovi

108 Human respiratory syncytial virus (RSV) and human parainfluenz

109 Human respiratory syncytial virus (RSV) and human parainfluenz

110 Respiratory syncytial virus (RSV) and human parainfluenz

111 Respiratory paramyxoviruses such as respiratory syncytial virus (RSV) and human parainfluenz

112 Respiratory syncytial virus (RSV) and human parainfluenz

113 Respiratory syncytial virus (RSV) and human rhinovirus (

114 We examined the differential impact of respiratory syncytial virus (RSV) and parainfluenza viru

115 s have long been recognized, with early-life respiratory syncytial virus (RSV) and rhinovirus (RV) lo

116 Respiratory syncytial virus (RSV) and Streptococcus pneu

117 Vaccines and antivirals against respiratory syncytial virus (RSV) are being developed, b

118 Infections with respiratory syncytial virus (RSV) are common and can cau

119 Lower respiratory tract infections from respiratory syncytial virus (RSV) are due, in part, to s

120 Vaccines and prophylactic antibodies against respiratory syncytial virus (RSV) are in development and

121 Lower respiratory tract infections by respiratory syncytial virus (RSV) are the foremost cause

122 Influenza A and B viruses and respiratory syncytial virus (RSV) are three common virus

123 Respiratory syncytial virus (RSV) belongs to the family

124 Respiratory syncytial virus (RSV) bronchiolitis in infan

125 plements." Herein, we describe an episode of respiratory syncytial virus (RSV) bronchiolitis with bac

126 The lack of a licensed vaccine for respiratory syncytial virus (RSV) can be partly attribut

127 Respiratory syncytial virus (RSV) can cause devastating

128 Respiratory syncytial virus (RSV) can cause severe respi

129 Respiratory syncytial virus (RSV) causes acute lower res

130 Respiratory syncytial virus (RSV) causes lower respirato

131 Respiratory syncytial virus (RSV) causes severe respirat

132 Respiratory syncytial virus (RSV) causes significant mor

133 and postfusion (post-F) conformations of the respiratory syncytial virus (RSV) F glycoprotein, is the

134 was investigated as a vector to express the respiratory syncytial virus (RSV) fusion (F) glycoprotei

135 ype 3 virus (rB/HPIV3) vector expressing the respiratory syncytial virus (RSV) fusion F glycoprotein

136 chimeric proteins, F/F and H/G, composed of respiratory syncytial virus (RSV) fusion protein (F) and

137 investigated whether children with a higher respiratory syncytial virus (RSV) genomic load are at a

138 Data on how respiratory syncytial virus (RSV) genotypes influence di

139 In the United States, the seasonality of respiratory syncytial virus (RSV) has traditionally been

140 Infection with respiratory syncytial virus (RSV) in neonatal mice leads

141 The significant burden of Respiratory Syncytial Virus (RSV) in pediatric and elder

142 However, both respiratory syncytial virus (RSV) infection and mutation

143 To address this, we developed a model of respiratory syncytial virus (RSV) infection based on wel

144 nto the cascade of immune events after acute respiratory syncytial virus (RSV) infection have been ob

145 ion to transmission of asymptomatic cases of respiratory syncytial virus (RSV) infection have not bee

146 infection with Heligmosomoides polygyrus on respiratory syncytial virus (RSV) infection in a mouse m

147 Respiratory syncytial virus (RSV) infection in infants h

148 Respiratory syncytial virus (RSV) infection induces asth

149 on of antiviral IFN signaling in response to respiratory syncytial virus (RSV) infection induces bact

150 BACKGROUND Respiratory syncytial virus (RSV) infection is a cause o

151 Respiratory syncytial virus (RSV) infection is a major c

152 Respiratory syncytial virus (RSV) infection is an import

153 Respiratory syncytial virus (RSV) infection is the major

154 Respiratory syncytial virus (RSV) infection is the numbe

155 Respiratory syncytial virus (RSV) infection of children

156 Children with acute respiratory syncytial virus (RSV) infection often develo

157 ligand 4 (Dll4) was upregulated on APC after respiratory syncytial virus (RSV) infection, and its inh

158 During primary respiratory syncytial virus (RSV) infection, anti-Axl mA

159 Here, using experimental human respiratory syncytial virus (RSV) infection, we investig

160 Using a murine CB6F1/J hybrid model of respiratory syncytial virus (RSV) infection, we previous

161 N) and inflammatory cytokines in response to respiratory syncytial virus (RSV) infection.

162 Few studies have examined respiratory syncytial virus (RSV) infections in adults.

163 Respiratory syncytial virus (RSV) infections remain a ma

164 Despite being a major health problem, respiratory syncytial virus (RSV) infections remain with

165 r developing antivirals for the treatment of respiratory syncytial virus (RSV) infections.

166 Respiratory syncytial virus (RSV) infects epithelial cel

167 The lack of a vaccine against respiratory syncytial virus (RSV) is a challenging and s

168 Respiratory syncytial virus (RSV) is a common cause of i

169 Human respiratory syncytial virus (RSV) is a common cause of s

170 Human respiratory syncytial virus (RSV) is a frequent cause of

171 g candidate vaccine antigen.IMPORTANCE Human respiratory syncytial virus (RSV) is a global leading ca

172 Respiratory syncytial virus (RSV) is a global respirator

173 Respiratory syncytial virus (RSV) is a highly contagious

174 Respiratory syncytial virus (RSV) is a leading cause of

175 Respiratory syncytial virus (RSV) is a leading cause of

176 Respiratory syncytial virus (RSV) is a leading cause of

177 Respiratory syncytial virus (RSV) is a leading cause of

178 Respiratory syncytial virus (RSV) is a leading cause of

179 Respiratory syncytial virus (RSV) is a leading cause of

180 Respiratory syncytial virus (RSV) is a leading cause of

181 Respiratory syncytial virus (RSV) is a leading cause of

182 Respiratory syncytial virus (RSV) is a leading cause of

183 Respiratory syncytial virus (RSV) is a leading pathogen

184 Respiratory syncytial virus (RSV) is a leading pediatric

185 Human respiratory syncytial virus (RSV) is a major cause of mo

186 Respiratory syncytial virus (RSV) is a major cause of re

187 Respiratory syncytial virus (RSV) is a major cause of up

188 Respiratory syncytial virus (RSV) is a major health care

189 Respiratory syncytial virus (RSV) is a major worldwide c

190 Respiratory syncytial virus (RSV) is a primary etiologic

191 Human respiratory syncytial virus (RSV) is a single-stranded R

192 Respiratory syncytial virus (RSV) is an exceptional muco

193 Respiratory syncytial virus (RSV) is an important cause

194 Human respiratory syncytial virus (RSV) is an important pathog

195 Respiratory syncytial virus (RSV) is an important pathog

196 Human respiratory syncytial virus (RSV) is associated with sev

197 fe lower respiratory illness (LRI) caused by respiratory syncytial virus (RSV) is increased during th

198 Respiratory syncytial virus (RSV) is increasingly recogn

199 The Human respiratory syncytial virus (RSV) is one of the most imp

200 Respiratory Syncytial Virus (RSV) is responsible for con

201 MPORTANCE Despite decades of research, human respiratory syncytial virus (RSV) is still a major healt

202 Although respiratory syncytial virus (RSV) is the leading cause o

203 Respiratory syncytial virus (RSV) is the leading cause o

204 Human respiratory syncytial virus (RSV) is the leading cause o

205 Respiratory syncytial virus (RSV) is the leading cause o

206 Respiratory syncytial virus (RSV) is the leading cause o

207 Infection with the respiratory syncytial virus (RSV) is the leading cause o

208 Human respiratory syncytial virus (RSV) is the leading cause o

209 Human respiratory syncytial virus (RSV) is the leading etiolog

210 Respiratory syncytial virus (RSV) is the main causative

211 Human respiratory syncytial virus (RSV) is the main cause of l

212 Respiratory syncytial virus (RSV) is the major cause of

213 Respiratory syncytial virus (RSV) is the most common cau

214 Respiratory syncytial virus (RSV) is the most common cau

215 Respiratory syncytial virus (RSV) is the most common cau

216 Human respiratory syncytial virus (RSV) is the most common cau

217 Respiratory syncytial virus (RSV) is the most common cau

218 Respiratory syncytial virus (RSV) is the most frequent c

219 Human respiratory syncytial virus (RSV) is the most frequent c

220 RATIONALE: Respiratory syncytial virus (RSV) is the most frequent c

221 Respiratory syncytial virus (RSV) is the most important

222 Human respiratory syncytial virus (RSV) is the most important

223 Respiratory syncytial virus (RSV) is the most important

224 Respiratory syncytial virus (RSV) is the most important

225 Respiratory syncytial virus (RSV) is the most important

226 Human respiratory syncytial virus (RSV) is the most prevalent

227 Respiratory syncytial virus (RSV) is the most significan

228 Respiratory syncytial virus (RSV) is the primary cause o

229 A licensed vaccine for respiratory syncytial virus (RSV) is unavailable, and pa

230 Respiratory syncytial virus (RSV) lower respiratory trac

231 Human respiratory syncytial virus (RSV) lower respiratory trac

232 Respiratory syncytial virus (RSV) lower respiratory trac

233 Passively acquired respiratory syncytial virus (RSV) neutralizing antibody

234 owing pulmonary viral infections with either respiratory syncytial virus (RSV) or influenza A virus (

235 Viral etiology was defined as respiratory syncytial virus (RSV) or rhinovirus (RV), in

236 ase phenotypes, the role of this receptor in respiratory syncytial virus (RSV) pathogenesis is contro

237 cificity of CRP for identifying bacterial vs respiratory syncytial virus (RSV) pneumonia in the Pneum

238 Respiratory syncytial virus (RSV) remains a major human

239 The infant immune response to respiratory syncytial virus (RSV) remains incompletely u

240 importance of bacterial infections following respiratory syncytial virus (RSV) remains unclear.

241 associated with enhanced rhinovirus (RV) and respiratory syncytial virus (RSV) replication.

242 OASL and the two mouse OASL homologs against respiratory syncytial virus (RSV) replication.

243 Respiratory syncytial virus (RSV) represents a threat to

244 Respiratory syncytial virus (RSV) represents the most co

245 The study was conducted during respiratory syncytial virus (RSV) seasons, before pneumo

246 There is no licensed vaccine against respiratory syncytial virus (RSV) since the failure of f

247 s are under way to develop a vaccine against respiratory syncytial virus (RSV) that will provide prot

248 ower respiratory tract illness (LRTI) due to respiratory syncytial virus (RSV) to inform selection of

249 Clinically meaningful endpoints for respiratory syncytial virus (RSV) treatment trials are l

250 ed phenotypic reversion of deoptimized human respiratory syncytial virus (RSV) vaccine candidates in

251 candidate.IMPORTANCE A safe and efficacious respiratory syncytial virus (RSV) vaccine remains elusiv

252 All live attenuated respiratory syncytial virus (RSV) vaccines that have adv

253 We have previously estimated that respiratory syncytial virus (RSV) was associated with 22

254 iLab assay for influenza A and B viruses and respiratory syncytial virus (RSV) was compared to a cent

255 characteristic recurrent epidemics of human respiratory syncytial virus (RSV) within communities may

256 Nearly all children are infected with respiratory syncytial virus (RSV) within the first 2 yea

257 There are two subgroups of respiratory syncytial virus (RSV), A and B, and within e

258 The latter includes respiratory syncytial virus (RSV), a human pathogen that

259 evelop an effective and safe vaccine against respiratory syncytial virus (RSV), a leading cause of re

260 The small hydrophobic (SH) gene of respiratory syncytial virus (RSV), a major cause of infa

261 Respiratory syncytial virus (RSV), a member of the Param

262 ibosomal subunit in response to infection by respiratory syncytial virus (RSV), an RNA virus of the P

263 ed rapid tests for influenza viruses, 32 for respiratory syncytial virus (RSV), and 13 for other resp

264 s (bNAbs) for viral infections, such as HIV, respiratory syncytial virus (RSV), and influenza, are in

265 simplex virus (HSV), human papilloma virus, respiratory syncytial virus (RSV), dengue and lenti viru

266 tion in early childhood, including that from respiratory syncytial virus (RSV), has been previously a

267 R (RT-PCR) and serology for the diagnosis of respiratory syncytial virus (RSV), human metapneumovirus

268 ial pattern of three common paramyxoviruses, Respiratory Syncytial Virus (RSV), Human Parainfluenza V

269 innate immune mechanism functioning against respiratory syncytial virus (RSV), in which the cellular

270 increasing age and female sex; detection of respiratory syncytial virus (RSV), influenza, rhinovirus

271 rway epithelial cells are the main target of respiratory syncytial virus (RSV), it also infects immun

272 During infection with respiratory syncytial virus (RSV), STAT1-deficient mice

273 such as Vesicular Stomatitis Virus (VSV) and Respiratory Syncytial Virus (RSV), without cytotoxicity.

274 Of 2322 HIV-uninfected children with respiratory syncytial virus (RSV)-associated LRTI, 1330

275 The high burden of respiratory syncytial virus (RSV)-associated morbidity a

276 role of Notch activation in a mouse model of respiratory syncytial virus (RSV)-exacerbated allergic a

277 xacerbation, we established a mouse model of respiratory syncytial virus (RSV)-induced exacerbation a

278 s with bronchiolitis were recruited: 12 were respiratory syncytial virus (RSV)-positive, 12 were RSV-

279 We studied preexisting respiratory syncytial virus (RSV)-specific serum and nas

280 develop such a system to study and forecast respiratory syncytial virus (RSV).

281 rus genus of the Paramyxoviridae family with Respiratory Syncytial Virus (RSV).

282 nfants at risk for severe disease because of respiratory syncytial virus (RSV).

283 There is a pressing need for a vaccine for respiratory syncytial virus (RSV).

284 e, which was similar to an antigenic site on respiratory syncytial virus (RSV).

285 compared hospitalization rates for HMPV and respiratory syncytial virus (RSV).

286 measles virus (MeV), mumps virus (MuV), and respiratory syncytial virus (RSV).

287 of lower respiratory tract illness caused by respiratory syncytial virus (RSV).

288 human rhinovirus (HRV), influenza virus, and respiratory syncytial virus (RSV).

289 ion due to human rhinovirus (HRV; n = 52) or respiratory syncytial virus (RSV; n = 83).

290 ct of BPZE1 on a common pediatric infection (respiratory syncytial virus [RSV]) in a preclinical mode

291 Of these, 199 were positive (46 for respiratory syncytial virus [RSV], 120 for influenza A,

292 ratory enteroviruses (EVs), influenza virus, respiratory syncytial viruses (RSVs), and coronaviruses

293 lyses of studies on tuberculosis, influenza, respiratory syncytial virus, SARS-Coronavirus and pneumo

294 ic categories including, asthma, aspiration, respiratory syncytial virus, sepsis-induced respiratory

295 we show, with a neutralization epitope from respiratory syncytial virus, that computational protein

296 formation and allowing for interrogations of respiratory syncytial virus virion assembly.

297 A high genomic load of respiratory syncytial virus was associated with a longer

298 < 0.0001) for increased mortality risk, and respiratory syncytial virus was associated with lowest m

299 Respiratory syncytial virus was more common among childr

300 ovirus, parainfluenza virus, rhinovirus, and respiratory syncytial virus were detected using PCR.